{"entity":{"id":"christophe-tournigand","kind":"person","name":"Christophe Tournigand","aka":[],"tldr":"Christophe Tournigand represents AP-HP Henri-Mondor University Hospitals Cancer Institute in the Organisation of European Cancer Institutes, which lists the centre among its full members in France.","summary":"Christophe Tournigand is listed by the Organisation of European Cancer Institutes (OECI) as the representative of AP-HP Henri-Mondor University Hospitals Cancer Institute, its full member in France. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"AP-HP Henri-Mondor University Hospitals Cancer Institute website","url":"https://iuc-hopitaux-u-mondor.aphp.fr/"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["henri-mondor"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of AP-HP Henri-Mondor University Hospitals Cancer Institute to the Organisation of European Cancer Institutes","institutionId":"henri-mondor","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"AP-HP Henri-Mondor University Hospitals Cancer Institute website","url":"https://iuc-hopitaux-u-mondor.aphp.fr/"}],"papers":[{"title":"Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study","journal":"J Clin Oncol","year":2015,"url":"https://doi.org/10.1200/jco.2015.63.4238","doi":"10.1200/jco.2015.63.4238","note":"Europe PMC author record matched by affiliation"},{"title":"Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study","journal":"J Clin Oncol","year":2023,"url":"https://doi.org/10.1200/jco.22.00686","doi":"10.1200/jco.22.00686","note":"Europe PMC author record matched by affiliation"}]},"route":"/people/christophe-tournigand/","neighbours":{"institution":[{"id":"henri-mondor","kind":"institution","name":"AP-HP Henri-Mondor University Hospitals Cancer Institute","route":"/institutions/henri-mondor/"},{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"}]}}